Publication and non-publication of clinical trials in PTSD: an overview

被引:4
|
作者
Suliman, Sharain [1 ]
van den Heuvel, Leigh [1 ]
Suryapranata, Alexandra [1 ]
Bisson, Jonathan, I [2 ]
Seedat, Soraya [1 ]
机构
[1] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Psychiat, POB 19063, ZA-7505 Tygerberg, South Africa
[2] Cardiff Univ, Div Psychol Med & Clin Neurosci, Sch Med, Cardiff, Wales
基金
英国医学研究理事会;
关键词
Trial registry; Posttraumatic stress disorder; Publication; REDUCING WASTE; REGISTRATION; PSYCHOLOGY; TIME;
D O I
10.1186/s41073-019-0074-6
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
BackgroundAlthough a large number of clinical trials on interventions demonstrating efficacy (or lack thereof) are conducted annually, much of this evidence is not accessible to scientists and clinicians.ObjectivesWe aimed to determine the publication rate of posttraumatic stress disorder (PTSD) trials that have been registered in clinical trial registries, and the factors associated with publication.MethodsTrials, completed on January 15, 2015, were identified via the US National Institutes of Health clinical trials registry, the European Union Clinical Trials Register and the WHO International Clinical Trials Registry Platform. A systematic search for publications (published by the end of March 2018) related to each of the registered trials were then performed.ResultsFour hundred and thirty-eight of 1982 potentially eligible trials were included. Only 34% of interventional trials were registered prior to initiation, 9% were registered within 2 months of starting and 20% after trial completion. Of the 438 included trials, 72% had generated peer-reviewed publications, while an additional 7% had disseminated results in some other form (such as on the trial database), 26 months after trial completion. Randomisation of a trial was the only factor individually associated with publication, in logistic regression analysis (p<0.001). Intervention type, university as sponsor and study registration prior to completion were factors that influenced the time to publication, using Cox regression (p<0.001).ConclusionsThis study underscores the importance of timely and accurate publication and dissemination of trial results, in order to avoid the potential waste of resources and to ensure research integrity and patient safety. We suggest that authors and journal editors adhere to conditions set out by the International Committee of Medical Journal Editors and that more diligent data sharing is encouraged through prospective trial registration and trial reporting websites.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Publication and non-publication of clinical trials in PTSD: an overview
    Sharain Suliman
    Leigh van den Heuvel
    Alexandra Suryapranata
    Jonathan I. Bisson
    Soraya Seedat
    [J]. Research Integrity and Peer Review, 4
  • [2] Discontinuation and non-publication of clinical trials in cardiovascular medicine
    Roddick, Alistair J.
    Chan, Fiona T. S.
    Stefaniak, James D.
    Zheng, Sean L.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 244 : 309 - 315
  • [3] Non-publication and delayed publication of randomized trials on vaccines: survey
    Manzoli, Lamberto
    Flacco, Maria Elena
    D'Addario, Maddalena
    Capasso, Lorenzo
    De Vito, Corrado
    Marzuillo, Carolina
    Villari, Paolo
    Ioannidis, John P. A.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [4] Non-publication of Phase-3 clinical trials in radiotherapy
    Perez-Alija, J.
    Gallego, P.
    Pedro, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S42 - S42
  • [5] Publication and non-publication of clinical trials:: longitudinal study of applications submitted to a research ethics committee
    von Elm, Erik
    Roellin, Alexandra
    Bluemle, Anette
    Huwiler, Karin
    Witschi, Mark
    Egger, Matthias
    [J]. SWISS MEDICAL WEEKLY, 2008, 138 (13-14) : 197 - 203
  • [6] An analysis of the rates of discontinuation and non-publication of colorectal cancer clinical trials
    Brett Traxler
    Corbin Walters
    Mopileola Tomi Adewumi
    Chase Meyer
    Madison Puckett
    Matt Vassar
    [J]. International Journal of Colorectal Disease, 2021, 36 : 2529 - 2532
  • [7] Factors affecting the non-publication of clinical trials of prevalent urological cancer
    Alhajahjeh, Abdulrahman
    Hmeidan, Majedah
    Abdulelah, Ahmed A.
    Al-Nezaa, Israa
    Al-Abbadi, Faris
    Dobbs, Ryan W.
    Sater, Zahi Abdul
    Al Awamlh, Bashir Al Hussein
    Lee, David I.
    Shahait, Mohammed
    [J]. WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [8] Non-publication of large randomized clinical trials: cross sectional analysis
    Jones, Christopher W.
    Handler, Lara
    Crowell, Karen E.
    Keil, Lukas G.
    Weaver, Mark A.
    Platts-Mills, Timothy F.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [9] An analysis of the rates of discontinuation and non-publication of colorectal cancer clinical trials
    Traxler, Brett
    Walters, Corbin
    Adewumi, Mopileola Tomi
    Meyer, Chase
    Puckett, Madison
    Vassar, Matt
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (11) : 2529 - 2532
  • [10] An observational analysis of discontinuation and non-publication of osteoarthritis trials
    Scott, J.
    Cooper, C. M.
    Checketts, J. X.
    Cutler, J.
    Boose, M.
    Morris, J.
    Vassar, M.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2018, 26 (09) : 1162 - 1169